Advances in Engineered Nanoparticles for the Treatment of Ischemic Stroke by Enhancing Angiogenesis

References

• Virani SS, Alonso A, Benjamin EJ, et al. American heart association council on, C. prevention statistics, S. stroke statistics, heart disease and stroke statistics-2020 update: a report from the American heart association. Circulation. 2020;141(9):e139–e596. doi:10.1161/CIR.0000000000000757
   PubMed Web of Science ®Google Scholar
• Hankey GJ. Stroke. Lancet. 2017;389(10069):641–654. doi:10.1016/S0140-6736(16)30962-X
   PubMed Web of Science ®Google Scholar
• Campbell BCV, De silva DA, Macleod MR, et al. Ischaemic stroke. Nat Rev Dis Primers. 2019;5(1):70. doi:10.1038/s41572-019-0118-8
   PubMed Web of Science ®Google Scholar
• Powers WJ, Rabinstein AA, Ackerson T, et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2019;50(12):e344–e418. doi:10.1161/STR.0000000000000211
   PubMed Web of Science ®Google Scholar
• Betts KA, Hurley D, Song J, et al. Real-world outcomes of acute ischemic stroke treatment with intravenous recombinant tissue plasminogen activator. J Stroke Cerebrovasc Dis. 2017;26(9):1996–2003. doi:10.1016/j.jstrokecerebrovasdis.2017.06.010
   PubMed Web of Science ®Google Scholar
• Jin H, Bi R, Hu J, et al. Elevated serum lactate dehydrogenase predicts unfavorable outcomes After rt-PA thrombolysis in ischemic stroke patients. Front Neurol. 2022;13:816216. doi:10.3389/fneur.2022.816216
   PubMed Web of Science ®Google Scholar
• Liao J, Li Y, Luo Y, et al. Recent advances in targeted nanotherapies for ischemic stroke. Mol Pharm. 2022;19(9):3026–3041. doi:10.1021/acs.molpharmaceut.2c00383
   PubMedGoogle Scholar
• Yang H, Luo Y, Hu H, et al. pH-Sensitive, cerebral vasculature-targeting hydroxyethyl starch functionalized nanoparticles for improved angiogenesis and neurological function recovery in ischemic stroke. Adv Healthc Mater. 2021;10(12):e2100028. doi:10.1002/adhm.202100028
   PubMed Web of Science ®Google Scholar
• Kaushal V, Schlichter LC. Mechanisms of microglia-mediated neurotoxicity in a new model of the stroke penumbra. J Neurosci. 2008;28(9):2221–2230. doi:10.1523/JNEUROSCI.5643-07.2008
   PubMed Web of Science ®Google Scholar
• Lo EH. A new penumbra: transitioning from injury into repair after stroke. Nat Med. 2008;14(5):497–500. doi:10.1038/nm1735
   PubMed Web of Science ®Google Scholar
• Hermann DM, Zechariah A. Implications of vascular endothelial growth factor for postischemic neurovascular remodeling. J Cereb Blood Flow Metab. 2009;29(10):1620–1643. doi:10.1038/jcbfm.2009.100
   PubMed Web of Science ®Google Scholar
• Snapyan M, Lemasson MS, Brill M, et al. Saghatelyan, Vasculature guides migrating neuronal precursors in the adult mammalian forebrain via brain-derived neurotrophic factor signaling. J Neurosci. 2009;29(13):4172–4188. doi:10.1523/JNEUROSCI.4956-08.2009
   PubMed Web of Science ®Google Scholar
• Teng H, Zhang ZG, Wang L, et al. Coupling of angiogenesis and neurogenesis in cultured endothelial cells and neural progenitor cells after stroke. J Cereb Blood Flow Metab. 2008;28(4):764–771. doi:10.1038/sj.jcbfm.9600573
   PubMed Web of Science ®Google Scholar
• Yang Y, Torbey MT. Angiogenesis and blood-brain barrier permeability in vascular remodeling after stroke. Curr Neuropharmacol. 2020;18(12):1250–1265. doi:10.2174/1570159X18666200720173316
   PubMed Web of Science ®Google Scholar
• Xie C, Liao J, Zhang N, et al. Advanced nano drug delivery systems for neuroprotection against ischemic stroke. Chin. Chem. Lett. 2024;35(2):109149. doi:10.1016/j.cclet.2023.109149
   Web of Science ®Google Scholar
• Yoo SY, Kwon SM. Angiogenesis and its therapeutic opportunities. Mediators Inflamm. 2013;2013:127170. doi:10.1155/2013/127170
   PubMed Web of Science ®Google Scholar
• Carmeliet P, Jain RK. Molecular mechanisms and clinical applications of angiogenesis. Nature. 2011;473(7347):298–307. doi:10.1038/nature10144
   PubMed Web of Science ®Google Scholar
• Adams RH, Alitalo K. Molecular regulation of angiogenesis and lymphangiogenesis. Nat Rev Mol Cell Biol. 2007;8(6):464–478. doi:10.1038/nrm2183
   PubMed Web of Science ®Google Scholar
• Freedman SB, Isner JM. Therapeutic angiogenesis for ischemic cardiovascular disease. J Mol Cell Cardiol. 2001;33(3):379–393. doi:10.1006/jmcc.2000.1329
   PubMed Web of Science ®Google Scholar
• Ribatti D, Conconi MT, Nussdorfer GG. Nonclassic endogenous novel [corrected] regulators of angiogenesis. Pharmacol Rev. 2007;59(2):185–205. doi:10.1124/pr.59.2.3
   PubMed Web of Science ®Google Scholar
• Zhao L, Johnson T, Liu D. Therapeutic angiogenesis of adipose-derived stem cells for ischemic diseases. Stem Cell Res Ther. 2017;8(1):125. doi:10.1186/s13287-017-0578-2
   PubMedGoogle Scholar
• Wang AZ, Langer R, Farokhzad OC. Nanoparticle delivery of cancer drugs. Annu Rev Med. 2012;63:185–198. doi:10.1146/annurev-med-040210-162544
   PubMed Web of Science ®Google Scholar
• Farokhzad OC, Langer R. Impact of nanotechnology on drug delivery. ACS Nano. 2009;3(1):16–20. doi:10.1021/nn900002m
   PubMed Web of Science ®Google Scholar
• Kaviarasi S, Yuba E, Harada A, Krishnan UM. Emerging paradigms in nanotechnology for imaging and treatment of cerebral ischemia. J Control Release. 2019;300:22–45. doi:10.1016/j.jconrel.2019.02.031
   PubMed Web of Science ®Google Scholar
• Knowland D, Arac A, Sekiguchi KJ, et al. Stepwise recruitment of transcellular and paracellular pathways underlies blood-brain barrier breakdown in stroke. Neuron. 2014;82(3):603–617. doi:10.1016/j.neuron.2014.03.003
   PubMed Web of Science ®Google Scholar
• Dong X, Gao J, Su Y, Wang Z. Nanomedicine for ischemic stroke. Int J Mol Sci. 2020;21(20):7600. doi:10.3390/ijms21207600
   PubMed Web of Science ®Google Scholar
• Pulicherla KK, Verma MK. Targeting therapeutics across the blood brain barrier (BBB), prerequisite towards thrombolytic therapy for cerebrovascular disorders-an overview and advancements. AAPS Pharm Sci Tech. 2015;16(2):223–233. doi:10.1208/s12249-015-0287-z
   PubMed Web of Science ®Google Scholar
• Chik MW, Hussain Z, Zulkefeli M, et al. Polymer-wrapped single-walled carbon nanotubes: a transformation toward better applications in healthcare. Drug Deliv Transl Res. 2019;9(2):578–594. doi:10.1007/s13346-018-0505-9
   PubMed Web of Science ®Google Scholar
• Panagiotou S, Saha S. Therapeutic benefits of nanoparticles in stroke. Front Neurosci. 2015;9:182. doi:10.3389/fnins.2015.00182
   PubMed Web of Science ®Google Scholar
• Sarmah D, Saraf J, Kaur H, et al. Stroke management: an emerging role of nanotechnology. Micromachines. 2017;8(9):1.
   Web of Science ®Google Scholar
• Kyle S, Saha S. Nanotechnology for the detection and therapy of stroke. Adv Healthc Mater. 2014;3(11):1703–1720. doi:10.1002/adhm.201400009
   PubMed Web of Science ®Google Scholar
• Shen J, Zhao Z, Shang W, et al. Fabrication and evaluation a transferrin receptor targeting nano-drug carrier for cerebral infarction treatment. Artif Cells Nanomed Biotechnol. 2019;47(1):192–200. doi:10.1080/21691401.2018.1548471
   PubMed Web of Science ®Google Scholar
• Carenza E, Jordan O, Martinez-San Segundo P, et al. Encapsulation of VEGF(165) into magnetic PLGA nanocapsules for potential local delivery and bioactivity in human brain endothelial cells. J Mater Chem B. 2015;3(12):2538–2544. doi:10.1039/C4TB01895H
   PubMed Web of Science ®Google Scholar
• Deng L, Zhang F, Wu Y, et al. RGD-modified nanocarrier-mediated targeted delivery of HIF-1alpha-AA Plasmid DNA to cerebrovascular endothelial cells for ischemic stroke treatment. ACS Biomater Sci Eng. 2019;5(11):6254–6264. doi:10.1021/acsbiomaterials.9b01362
   PubMed Web of Science ®Google Scholar
• Wang C, Lin G, Luan Y, et al. HIF-prolyl hydroxylase 2 silencing using siRNA delivered by MRI-visible nanoparticles improves therapy efficacy of transplanted EPCs for ischemic stroke. Biomaterials. 2019;197:229–243. doi:10.1016/j.biomaterials.2018.05.053
   PubMed Web of Science ®Google Scholar
• Shen J, Zhao Z, Shang W, et al. Fabrication of a nano polymer wrapping Meg3 ShRNA plasmid for the treatment of cerebral infarction. Artif Cells Nanomed Biotechnol. 2018;46(sup2):894–903. doi:10.1080/21691401.2018.1471483
   PubMed Web of Science ®Google Scholar
• Ferreira R, Fonseca MC, Santos T, et al. Retinoic acid-loaded polymeric nanoparticles enhance vascular regulation of neural stem cell survival and differentiation after ischaemia. Nanoscale. 2016;8(15):8126–8137. doi:10.1039/C5NR09077F
   PubMed Web of Science ®Google Scholar
• Petro M, Jaffer H, Yang J, Kabu S, Morris VB, Labhasetwar V. Tissue plasminogen activator followed by antioxidant-loaded nanoparticle delivery promotes activation/mobilization of progenitor cells in infarcted rat brain. Biomaterials. 2016;81:169–180. doi:10.1016/j.biomaterials.2015.12.009
   PubMed Web of Science ®Google Scholar
• Lu X, Dong J, Zheng D, Li X, Ding D, Xu H. Reperfusion combined with intraarterial administration of resveratrol-loaded nanoparticles improved cerebral ischemia-reperfusion injury in rats. Nanomedicine. 2020;28:102208. doi:10.1016/j.nano.2020.102208
   PubMed Web of Science ®Google Scholar
• Li X, Han Z, Wang T, et al. Cerium oxide nanoparticles with antioxidative neurorestoration for ischemic stroke. Biomaterials. 2022;291:121904. doi:10.1016/j.biomaterials.2022.121904
   PubMed Web of Science ®Google Scholar
• Wang J, Su Q, Lv Q, et al. Oxygen-generating cyanobacteria powered by upconversion-nanoparticles-converted near-infrared light for ischemic stroke treatment. Nano Lett. 2021;21(11):4654–4665. doi:10.1021/acs.nanolett.1c00719
   PubMed Web of Science ®Google Scholar
• Li Y, Zhang M, Li S, et al. Selective ischemic-hemisphere targeting Ginkgolide B liposomes with improved solubility and therapeutic efficacy for cerebral ischemia-reperfusion injury. Asian J Pharm Sci. 2023;18(2):100783. doi:10.1016/j.ajps.2023.100783
   PubMed Web of Science ®Google Scholar
• Xia Y, Ling X, Hu G, et al. Small extracellular vesicles secreted by human iPSC-derived MSC enhance angiogenesis through inhibiting STAT3-dependent autophagy in ischemic stroke. Stem Cell Res Ther. 2020;11(1):313. doi:10.1186/s13287-020-01834-0
   PubMed Web of Science ®Google Scholar
• Gregorius J, Wang C, Stambouli O, et al. Small extracellular vesicles obtained from hypoxic mesenchymal stromal cells have unique characteristics that promote cerebral angiogenesis, brain remodeling and neurological recovery after focal cerebral ischemia in mice. Basic Res Cardiol. 2021;116(1):40. doi:10.1007/s00395-021-00881-9
   PubMed Web of Science ®Google Scholar
• Mohamud Yusuf A, Hagemann N, Zhang X, et al. Acid sphingomyelinase deactivation post-ischemia promotes brain angiogenesis and remodeling by small extracellular vesicles. Basic Res Cardiol. 2022;117(1):43. doi:10.1007/s00395-022-00950-7
   PubMed Web of Science ®Google Scholar
• Zhang L, Wei W, Ai X, et al. Extracellular vesicles from hypoxia-preconditioned microglia promote angiogenesis and repress apoptosis in stroke mice via the TGF-beta/Smad2/3 pathway. Cell Death Dis. 2021;12(11):1068. doi:10.1038/s41419-021-04363-7
   PubMed Web of Science ®Google Scholar
• Wang C, Yang X, Jiang Y, et al. Targeted delivery of fat extract by platelet membrane-cloaked nanocarriers for the treatment of ischemic stroke. J Nanobiotechnology. 2022;20(1):249. doi:10.1186/s12951-022-01461-2
   PubMed Web of Science ®Google Scholar
• Katas H, Wen CY, Siddique MI, Hussain Z, Mohd Fadhil FH. Thermoresponsive curcumin/DsiRNA nanoparticle gels for the treatment of diabetic wounds: synthesis and drug release. Ther Deliv. 2017;8(3):137–150. doi:10.4155/tde-2016-0075
   PubMedGoogle Scholar
• Hussain Z, Katas H, Yan SL, Jamaludin D. Efficient colonic delivery of DsiRNA by pectin-coated polyelectrolyte complex nanoparticles: preparation, characterization and improved gastric survivability. Curr Drug Deliv. 2017;14(7):1016–1027. doi:10.2174/1567201814666170224142446
   PubMed Web of Science ®Google Scholar
• Ei Thu H, Hussain Z, Shuid AN. New insight in improving therapeutic efficacy of antipsychotic agents: an overview of improved in vitro and in vivo performance, efficacy upgradation and future prospects. Curr Drug Targets. 2018;19(8):865–876. doi:10.2174/1389450117666161125174625
   PubMed Web of Science ®Google Scholar
• Zia MA, Sohail M, Minhas M, et al. HEMA based pH-sensitive semi IPN microgels for oral delivery; a rationale approach for ketoprofen. Drug Dev Ind Pharm. 2020;46(2):272–282. doi:10.1080/03639045.2020.1716378
   PubMed Web of Science ®Google Scholar
• Chen W, Jiang L, Hu Y, et al. Nanomedicines, an emerging therapeutic regimen for treatment of ischemic cerebral stroke: a review. J Control Release. 2021;340:342–360. doi:10.1016/j.jconrel.2021.10.020
   PubMed Web of Science ®Google Scholar
• Masserini M. Nanoparticles for brain drug delivery. ISRN Biochem. 2013;2013:238428.
   PubMedGoogle Scholar
• Chen C, Mu XY, Zhou Y, et al. Ginsenoside Rg1 enhances the resistance of hematopoietic stem/progenitor cells to radiation-induced aging in mice. Acta Pharmacol Sin. 2014;35(1):143–150. doi:10.1038/aps.2013.136
   PubMed Web of Science ®Google Scholar
• Wang J, Li D, Hou J, Lei H. Protective effects of geniposide and ginsenoside Rg1 combination treatment on rats following cerebral ischemia are mediated via microglial microRNA‑155‑5p inhibition. Mol Med Rep. 2018;17(2):3186–3193. doi:10.3892/mmr.2017.8221
   PubMed Web of Science ®Google Scholar
• Xie CL, Li JH, Wang WW, Zheng GQ, Wang LX. Neuroprotective effect of ginsenoside-Rg1 on cerebral ischemia/reperfusion injury in rats by downregulating protease-activated receptor-1 expression. Life Sci. 2015;121:145–151. doi:10.1016/j.lfs.2014.12.002
   PubMed Web of Science ®Google Scholar
• Li Y-B, Wang Y, Tang J-P, Chen D, Wang S-L. Neuroprotective effects of ginsenoside Rg1-induced neural stem cell transplantation on hypoxic-ischemic encephalopathy. Neural Regen Res. 2015;10(5):753–759. doi:10.4103/1673-5374.156971
   PubMed Web of Science ®Google Scholar
• Shen HH. Core Concept: circumventing the blood-brain barrier. Proc Natl Acad Sci U S A. 2017;114(43):11261–11263. doi:10.1073/pnas.1716187114
   PubMed Web of Science ®Google Scholar
• Nogueira-Librelotto DR, Codevilla CF, Farooqi A, Rolim CM. Transferrin-conjugated nanocarriers as active-targeted drug delivery platforms for cancer therapy. Curr Pharm Des. 2017;23(3):454–466. doi:10.2174/1381612822666161026162347
   PubMed Web of Science ®Google Scholar
• Han L, Li J, Huang S, et al. Peptide-conjugated polyamidoamine dendrimer as a nanoscale tumor-targeted T1 magnetic resonance imaging contrast agent. Biomaterials. 2011;32(11):2989–2998. doi:10.1016/j.biomaterials.2011.01.005
   PubMed Web of Science ®Google Scholar
• Zhang L, Wang T, Li Q, et al. Fabrication of novel vesicles of triptolide for antirheumatoid activity with reduced toxicity in vitro and in vivo. Int J Nanomed. 2016;11:2663–2673. doi:10.2147/IJN.S104593
   PubMed Web of Science ®Google Scholar
• Geng X, Ye H, Feng Z, et al. Synthesis and characterization of cisplatin-loaded, EGFR-targeted biopolymer and in vitro evaluation for targeted delivery. J Biomed Mater Res A. 2012;100(10):2839–2848. doi:10.1002/jbm.a.34207
   PubMedGoogle Scholar
• Zhang L, Chang J, Zhao Y, et al. Fabrication of a triptolide-loaded and poly-gamma-glutamic acid-based amphiphilic nanoparticle for the treatment of rheumatoid arthritis. Int J Nanomed. 2018;13:2051–2064. doi:10.2147/IJN.S151233
   PubMed Web of Science ®Google Scholar
• Carenza E, Barcelo V, Morancho A, et al. In vitro angiogenic performance and in vivo brain targeting of magnetized endothelial progenitor cells for neurorepair therapies. Nanomedicine. 2014;10(1):225–234. doi:10.1016/j.nano.2013.06.005
   PubMed Web of Science ®Google Scholar
• Bible E, Qutachi O, Chau DY, Alexander MR, Shakesheff KM, Modo M. Neo-vascularization of the stroke cavity by implantation of human neural stem cells on VEGF-releasing PLGA microparticles. Biomaterials. 2012;33(30):7435–7446. doi:10.1016/j.biomaterials.2012.06.085
   PubMed Web of Science ®Google Scholar
• Formiga FR, Pelacho B, Garbayo E, et al. Sustained release of VEGF through PLGA microparticles improves vasculogenesis and tissue remodeling in an acute myocardial ischemia-reperfusion model. J Control Release. 2010;147(1):30–37. doi:10.1016/j.jconrel.2010.07.097
   PubMed Web of Science ®Google Scholar
• Golub JS, Kim YT, Duvall CL, et al. Sustained VEGF delivery via PLGA nanoparticles promotes vascular growth. Am J Physiol Heart Circ Physiol. 2010;298(6):H1959–65. doi:10.1152/ajpheart.00199.2009
   PubMed Web of Science ®Google Scholar
• Rhim T, Lee DY, Lee M. Drug delivery systems for the treatment of ischemic stroke. Pharm Res. 2013;30(10):2429–2444. doi:10.1007/s11095-012-0959-2
   PubMed Web of Science ®Google Scholar
• Des Rieux A, Ucakar BP, Mupendwa B, et al. 3D systems delivering VEGF to promote angiogenesis for tissue engineering. J Control Release. 2011;150(3):272–278. doi:10.1016/j.jconrel.2010.11.028
   PubMed Web of Science ®Google Scholar
• Borselli C, Ungaro F, Oliviero O, et al. Bioactivation of collagen matrices through sustained VEGF release from PLGA microspheres. J Biomed Mater Res A. 2010;92(1):94–102. doi:10.1002/jbm.a.32332
   PubMedGoogle Scholar
• Kim J, Cao L, Shvartsman D, Silva EA, Mooney DJ. Targeted delivery of nanoparticles to ischemic muscle for imaging and therapeutic angiogenesis. Nano Lett. 2011;11(2):694–700. doi:10.1021/nl103812a
   PubMed Web of Science ®Google Scholar
• Liu X, Kaminski MD, Chen H, Torno M, Taylor L, Rosengart AJ. Synthesis and characterization of highly-magnetic biodegradable poly(d,l-lactide-co-glycolide) nanospheres. J Control Release. 2007;119(1):52–58. doi:10.1016/j.jconrel.2006.11.031
   PubMed Web of Science ®Google Scholar
• Okassa LN, Marchais H, Douziech-Eyrolles L, et al. Optimization of iron oxide nanoparticles encapsulation within poly(d,l-lactide-co-glycolide) sub-micron particles. Eur J Pharm Biopharm. 2007;67(1):31–38. doi:10.1016/j.ejpb.2006.12.020
   PubMed Web of Science ®Google Scholar
• Khan M, Dhammu TS, Matsuda F, et al. Promoting endothelial function by S-nitrosoglutathione through the HIF-1alpha/VEGF pathway stimulates neurorepair and functional recovery following experimental stroke in rats. Drug Des Devel Ther. 2015;9:2233–2247. doi:10.2147/DDDT.S77115
   PubMed Web of Science ®Google Scholar
• Doeppner TR, Mlynarczuk-Bialy I, Kuckelkorn U, et al. The novel proteasome inhibitor BSc2118 protects against cerebral ischaemia through HIF1A accumulation and enhanced angioneurogenesis. Brain. 2012;135(Pt 11):3282–3297. doi:10.1093/brain/aws269
   PubMedGoogle Scholar
• Zhong Q, Zhou Y, Ye W, Cai T, Zhang X, Deng DY. Hypoxia-inducible factor 1-alpha-AA-modified bone marrow stem cells protect PC12 cells from hypoxia-induced apoptosis, partially through VEGF/PI3K/Akt/FoxO1 pathway. Stem Cells Dev. 2012;21(14):2703–2717. doi:10.1089/scd.2011.0604
   PubMed Web of Science ®Google Scholar
• Bharadwaj VN, Nguyen DT, Kodibagkar VD, Stabenfeldt SE. Nanoparticle-based therapeutics for brain injury. Adv Healthc Mater. 2018;7(1). doi:10.1002/adhm.201700668
   PubMed Web of Science ®Google Scholar
• Berra E, Benizri E, Ginouves A, et al. HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1alpha in normoxia. EMBO J. 2003;22(16):4082–4090. doi:10.1093/emboj/cdg392
   PubMed Web of Science ®Google Scholar
• Wu S, Nishiyama N, Kano MR, et al. Enhancement of angiogenesis through stabilization of hypoxia-inducible factor-1 by silencing prolyl hydroxylase domain-2 gene. Mol Ther. 2008;16(7):1227–1234. doi:10.1038/mt.2008.90
   PubMed Web of Science ®Google Scholar
• Jaakkola P, Mole DR, Tian YM, et al. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science. 2001;292(5516):468–472. doi:10.1126/science.1059796
   PubMed Web of Science ®Google Scholar
• Oh YK, Park TG. siRNA delivery systems for cancer treatment. Adv Drug Deliv Rev. 2009;61(10):850–862. doi:10.1016/j.addr.2009.04.018
   PubMed Web of Science ®Google Scholar
• Hong CA, Nam YS. Functional nanostructures for effective delivery of small interfering RNA therapeutics. Theranostics. 2014;4(12):1211–1232. doi:10.7150/thno.8491
   PubMed Web of Science ®Google Scholar
• Lin G, Zhu W, Yang L, et al. Delivery of siRNA by MRI-visible nanovehicles to overcome drug resistance in MCF-7/ADR human breast cancer cells. Biomaterials. 2014;35(35):9495–9507. doi:10.1016/j.biomaterials.2014.07.049
   PubMed Web of Science ®Google Scholar
• Liu G, Xie J, Zhang F, et al. N-Alkyl-PEI-functionalized iron oxide nanoclusters for efficient siRNA delivery. Small. 2011;7(19):2742–2749. doi:10.1002/smll.201100825
   PubMed Web of Science ®Google Scholar
• Yan B, Yao J, Liu JY, et al. lncRNA-MIAT regulates microvascular dysfunction by functioning as a competing endogenous RNA. Circ Res. 2015;116(7):1143–1156. doi:10.1161/CIRCRESAHA.116.305510
   PubMed Web of Science ®Google Scholar
• Yan H, Yuan J, Gao L, et al. Long noncoding RNA MEG3 activation of p53 mediates ischemic neuronal death in stroke. Neuroscience. 2016;337:191–199. doi:10.1016/j.neuroscience.2016.09.017
   PubMed Web of Science ®Google Scholar
• Zhou Y, Cheunsuchon P, Nakayama Y, et al. Activation of paternally expressed genes and perinatal death caused by deletion of the Gtl2 gene. Development. 2010;137(16):2643–2652. doi:10.1242/dev.045724
   PubMed Web of Science ®Google Scholar
• Gordon FE, Nutt CL, Cheunsuchon P, et al. Increased expression of angiogenic genes in the brains of mouse meg3-null embryos. Endocrinology. 2010;151(6):2443–2452. doi:10.1210/en.2009-1151
   PubMed Web of Science ®Google Scholar
• Su W, Xie W, Shang Q, Su B. The Long Noncoding RNA MEG3 Is Downregulated and Inversely Associated with VEGF Levels in Osteoarthritis. Biomed Res Int. 2015;2015:356893. doi:10.1155/2015/356893
   PubMed Web of Science ®Google Scholar
• He Y, Luo Y, Liang B, Ye L, Lu G, He W. Potential applications of MEG3 in cancer diagnosis and prognosis. Oncotarget. 2017;8(42):73282–73295. doi:10.18632/oncotarget.19931
   PubMedGoogle Scholar
• Hui F, Nguyen CTO, He Z, et al. Retinal and cortical blood flow dynamics following systemic blood-neural barrier disruption. Front Neurosci. 2017;11:568. doi:10.3389/fnins.2017.00568
   PubMed Web of Science ®Google Scholar
• Liu Z, Zhang L, He Q, et al. Effect of Baicalin-loaded PEGylated cationic solid lipid nanoparticles modified by OX26 antibody on regulating the levels of baicalin and amino acids during cerebral ischemia-reperfusion in rats. Int J Pharm. 2015;489(1–2):131–138. doi:10.1016/j.ijpharm.2015.04.049
   PubMedGoogle Scholar
• Peng SF, Tseng MT, Ho YC, Wei MC, Liao ZX, Sung HW. Mechanisms of cellular uptake and intracellular trafficking with chitosan/DNA/poly(gamma-glutamic acid) complexes as a gene delivery vector. Biomaterials. 2011;32(1):239–248. doi:10.1016/j.biomaterials.2010.08.081
   PubMed Web of Science ®Google Scholar
• Deng J, Wen Y, Wang C, et al. Efficient intracellular gene delivery using the formulation composed of poly (L-glutamic acid) grafted polyethylenimine and histone. Pharm Res. 2011;28(4):812–826. doi:10.1007/s11095-010-0335-z
   PubMed Web of Science ®Google Scholar
• Sawada M, Matsumoto M, Sawamoto K. Vascular regulation of adult neurogenesis under physiological and pathological conditions. Front Neurosci. 2014;8:53. doi:10.3389/fnins.2014.00053
   PubMed Web of Science ®Google Scholar
• Maden M. Retinoic acid in the development, regeneration and maintenance of the nervous system. Nat Rev Neurosci. 2007;8(10):755–765. doi:10.1038/nrn2212
   PubMed Web of Science ®Google Scholar
• Saito A, Sugawara A, Uruno A, et al. All-trans retinoic acid induces in vitro angiogenesis via retinoic acid receptor: possible involvement of paracrine effects of endogenous vascular endothelial growth factor signaling. Endocrinology. 2007;148(3):1412–1423. doi:10.1210/en.2006-0900
   PubMed Web of Science ®Google Scholar
• Jin Y, Raviv N, Barnett A, Bambakidis NC, Filichia E, Luo Y. The shh signaling pathway is upregulated in multiple cell types in cortical ischemia and influences the outcome of stroke in an animal model. PLoS One. 2015;10(4):e0124657. doi:10.1371/journal.pone.0124657
   PubMed Web of Science ®Google Scholar
• Zhang X, Zhou Y, Li H, et al. Intravenous administration of DPSCs and BDNF improves neurological performance in rats with focal cerebral ischemia. Int J Mol Med. 2018;41(6):3185–3194. doi:10.3892/ijmm.2018.3517
   PubMed Web of Science ®Google Scholar
• Zhang ZG, Zhang L, Tsang W, et al. Correlation of VEGF and angiopoietin expression with disruption of blood-brain barrier and angiogenesis after focal cerebral ischemia. J Cereb Blood Flow Metab. 2002;22(4):379–392. doi:10.1097/00004647-200204000-00002
   PubMed Web of Science ®Google Scholar
• Li S, Nih LR, Bachman H, et al. Hydrogels with precisely controlled integrin activation dictate vascular patterning and permeability. Nat Mater. 2017;16(9):953–961. doi:10.1038/nmat4954
   PubMed Web of Science ®Google Scholar
• Nih LR, Gojgini ST, Carmichael S, Segura T. Dual-function injectable angiogenic biomaterial for the repair of brain tissue following stroke. Nat Mater. 2018;17(7):642–651. doi:10.1038/s41563-018-0083-8
   PubMed Web of Science ®Google Scholar
• Campbell ID, Humphries MJ. Integrin structure, activation, and interactions. Cold Spring Harb Perspect Biol. 2011;3(3):a004994–a004994. doi:10.1101/cshperspect.a004994
   PubMed Web of Science ®Google Scholar
• Sun J, Yu L, Huang S, Lai X, Milner R, Li L. Vascular expression of angiopoietin1, alpha5beta1 integrin and tight junction proteins is tightly regulated during vascular remodeling in the post-ischemic brain. Neuroscience. 2017;362:248–256. doi:10.1016/j.neuroscience.2017.08.040
   PubMed Web of Science ®Google Scholar
• Feng Y, Mrksich M. The synergy peptide PHSRN and the adhesion peptide RGD mediate cell adhesion through a common mechanism. Biochemistry. 2004;43(50):15811–15821.
   PubMed Web of Science ®Google Scholar
• Wu CC, Wang LC, Su YT, Wei WY, Tsai KJ. Synthetic alpha5beta1 integrin ligand PHSRN is proangiogenic and neuroprotective in cerebral ischemic stroke. Biomaterials. 2018;185:142–154. doi:10.1016/j.biomaterials.2018.09.014
   PubMed Web of Science ®Google Scholar
• Cui W, Liu R, Jin H, et al. pH gradient difference around ischemic brain tissue can serve as a trigger for delivering polyethylene glycol-conjugated urokinase nanogels. J Control Release. 2016;225:53–63. doi:10.1016/j.jconrel.2016.01.028
   PubMed Web of Science ®Google Scholar
• Luo Y, Yang H, Zhou YF, Hu B. Dual and multi-targeted nanoparticles for site-specific brain drug delivery. J Control Release. 2020;317:195–215. doi:10.1016/j.jconrel.2019.11.037
   PubMed Web of Science ®Google Scholar
• Cheng R, Meng F, Deng C, Klok HA, Zhong Z. Dual and multi-stimuli responsive polymeric nanoparticles for programmed site-specific drug delivery. Biomaterials. 2013;34(14):3647–3657. doi:10.1016/j.biomaterials.2013.01.084
   PubMed Web of Science ®Google Scholar
• Hu H, Li Y, Zhou Q, et al. Redox-sensitive hydroxyethyl starch-doxorubicin conjugate for tumor targeted drug delivery. ACS Appl Mater Interfaces. 2016;8(45):30833–30844. doi:10.1021/acsami.6b11932
   PubMed Web of Science ®Google Scholar
• Hu H, Xiao C, Wu H, et al. Nanocolloidosomes with selective drug release for active tumor-targeted imaging-guided photothermal/chemo combination therapy. ACS Appl Mater Interfaces. 2017;9(48):42225–42238. doi:10.1021/acsami.7b14796
   PubMed Web of Science ®Google Scholar
• Esquiva G, Grayston A, Rosell A. Revascularization and endothelial progenitor cells in stroke. Am J Physiol Cell Physiol. 2018;315(5):C664–C674. doi:10.1152/ajpcell.00200.2018
   PubMed Web of Science ®Google Scholar
• Aziz A, Haywood NJ, Cordell PA, et al. Insulin like growth factor-binding protein-1 improves vascular endothelial repair in male mice in the setting of insulin resistance. Endocrinology. 2018;159(2):696–709. doi:10.1210/en.2017-00572
   PubMed Web of Science ®Google Scholar
• Wang H, Yin YG, Huang H, et al. Transplantation of EPCs overexpressing PDGFR-beta promotes vascular repair in the early phase after vascular injury. BMC Cardiovasc Disord. 2016;16(1):179. doi:10.1186/s12872-016-0353-9
   PubMedGoogle Scholar
• Wang H, Yin Y, Li W, et al. Over-expression of PDGFR-beta promotes PDGF-induced proliferation, migration, and angiogenesis of EPCs through PI3K/Akt signaling pathway. PLoS One. 2012;7(2):e30503. doi:10.1371/journal.pone.0030503
   PubMed Web of Science ®Google Scholar
• Seto SW, Chang D, Jenkins A, Bensoussan A, Kiat H. Angiogenesis in ischemic stroke and angiogenic effects of Chinese herbal medicine. J Clin Med. 2016;5(6):56. doi:10.3390/jcm5060056
   PubMed Web of Science ®Google Scholar
• Ergul A, Alhusban A, Fagan SC. Angiogenesis: a harmonized target for recovery after stroke. Stroke. 2012;43(8):2270–2274. doi:10.1161/STROKEAHA.111.642710
   PubMed Web of Science ®Google Scholar
• Manoonkitiwongsa PS, Jackson-Friedman C, McMillan PJ, Schultz RL, Lyden PD. Angiogenesis after stroke is correlated with increased numbers of macrophages: the clean-up hypothesis. J Cereb Blood Flow Metab. 2001;21(10):1223–1231. doi:10.1097/00004647-200110000-00011
   PubMed Web of Science ®Google Scholar
• Fang W, Zhai X, Han D, et al. CCR2-dependent monocytes/macrophages exacerbate acute brain injury but promote functional recovery after ischemic stroke in mice. Theranostics. 2018;8(13):3530–3543. doi:10.7150/thno.24475
   PubMed Web of Science ®Google Scholar
• Zong X, Li Y, Liu C, et al. Theta-burst transcranial magnetic stimulation promotes stroke recovery by vascular protection and neovascularization. Theranostics. 2020;10(26):12090–12110. doi:10.7150/thno.51573
   PubMed Web of Science ®Google Scholar
• Jickling GC, Liu D, Stamova B, et al. Hemorrhagic transformation after ischemic stroke in animals and humans. J Cereb Blood Flow Metab. 2014;34(2):185–199. doi:10.1038/jcbfm.2013.203
   PubMed Web of Science ®Google Scholar
• Villaran RF, de Pablos RM, Arguelles S, et al. The intranigral injection of tissue plasminogen activator induced blood-brain barrier disruption, inflammatory process and degeneration of the dopaminergic system of the rat. Neurotoxicology. 2009;30(3):403–413. doi:10.1016/j.neuro.2009.02.011
   PubMed Web of Science ®Google Scholar
• Wahlgren N, Ahmed N, Davalos A, et al. Thrombolysis with alteplase 3-4.5 h after acute ischaemic stroke (SITS-ISTR): an observational study. Lancet. 2008;372(9646):1303–1309. doi:10.1016/S0140-6736(08)61339-2
   PubMed Web of Science ®Google Scholar
• Moskowitz MA, Lo EH, Iadecola C. The science of stroke: mechanisms in search of treatments. Neuron. 2010;67(2):181–198. doi:10.1016/j.neuron.2010.07.002
   PubMed Web of Science ®Google Scholar
• Sun T, Jiang C. Stimuli-responsive drug delivery systems triggered by intracellular or subcellular microenvironments. Adv Drug Deliv Rev. 2023;196:114773. doi:10.1016/j.addr.2023.114773
   PubMed Web of Science ®Google Scholar
• Zhu W, Huang L, Li Y, et al. Exosomes derived from human bone marrow mesenchymal stem cells promote tumor growth in vivo. Cancer Lett. 2012;315(1):28–37. doi:10.1016/j.canlet.2011.10.002
   PubMed Web of Science ®Google Scholar
• Urban N, Guillemot F. Neurogenesis in the embryonic and adult brain: same regulators, different roles. Front Cell Neurosci. 2014;8:396. doi:10.3389/fncel.2014.00396
   PubMed Web of Science ®Google Scholar
• Dibajnia P, Morshead CM. Role of neural precursor cells in promoting repair following stroke. Acta Pharmacol Sin. 2013;34(1):78–90. doi:10.1038/aps.2012.107
   PubMed Web of Science ®Google Scholar
• Huang TT, Zou Y, Corniola R. Oxidative stress and adult neurogenesis--effects of radiation and superoxide dismutase deficiency. Semin Cell Dev Biol. 2012;23(7):738–744. doi:10.1016/j.semcdb.2012.04.003
   PubMed Web of Science ®Google Scholar
• Mizuma A, Yenari MA. Anti-inflammatory targets for the treatment of reperfusion injury in stroke. Front Neurol. 2017;8:467. doi:10.3389/fneur.2017.00467
   PubMed Web of Science ®Google Scholar
• Chelluboina B, Klopfenstein JD, Gujrati M, Rao JS, Veeravalli KK. Temporal regulation of apoptotic and anti-apoptotic molecules after middle cerebral artery occlusion followed by reperfusion. Mol Neurobiol. 2014;49(1):50–65. doi:10.1007/s12035-013-8486-7
   PubMed Web of Science ®Google Scholar
• Carta G, Poddighe L, Serra MP, et al. Preventive effects of resveratrol on endocannabinoid system and synaptic protein modifications in rat cerebral cortex challenged by bilateral common carotid artery occlusion and reperfusion. Int J Mol Sci. 2018;19(2):426. doi:10.3390/ijms19020426
   PubMed Web of Science ®Google Scholar
• Fonseca-Santos B, Satake CY, Calixto GMF, Dos Santos AM, Chorilli M. Trans-resveratrol-loaded nonionic lamellar liquid-crystalline systems: structural, rheological, mechanical, textural, and bioadhesive characterization and evaluation of in vivo anti-inflammatory activity. Int J Nanomed. 2017;12:6883–6893. doi:10.2147/IJN.S138629
   PubMed Web of Science ®Google Scholar
• Lu X, Xu H, Sun B, Zhu Z, Zheng D, Li X. Enhanced neuroprotective effects of resveratrol delivered by nanoparticles on hydrogen peroxide-induced oxidative stress in rat cortical cell culture. Mol Pharm. 2013;10(5):2045–2053. doi:10.1021/mp400056c
   PubMedGoogle Scholar
• Barui AK, Jhelum P, Nethi SK, et al. Potential therapeutic application of zinc oxide nanoflowers in the cerebral ischemia rat model through neuritogenic and neuroprotective properties. Bioconjug Chem. 2020;31(3):895–906. doi:10.1021/acs.bioconjchem.0c00030
   PubMed Web of Science ®Google Scholar
• Kim CK, Kim T, Choi IY, et al. Ceria nanoparticles that can protect against ischemic stroke. Angew Chem Int Ed Engl. 2012;51(44):11039–11043. doi:10.1002/anie.201203780
   PubMed Web of Science ®Google Scholar
• Liao J, Li Y, Fan L, et al. Bioactive ceria nanoenzymes target mitochondria in reperfusion injury to treat ischemic stroke. ACS Nano. 2024;2014:1.
   Google Scholar
• He L, Huang G, Liu H, Sang C, Liu X, Chen T. Highly bioactive zeolitic imidazolate framework-8-capped nanotherapeutics for efficient reversal of reperfusion-induced injury in ischemic stroke. Sci Adv. 2020;6(12):eaay9751. doi:10.1126/sciadv.aay9751
   PubMed Web of Science ®Google Scholar
• Wang S, Ma F, Huang L, et al. Dl-3-n-Butylphthalide (NBP): a promising therapeutic agent for ischemic stroke. CNS Neurol Disord Drug Targets. 2018;17(5):338–347. doi:10.2174/1871527317666180612125843
   PubMed Web of Science ®Google Scholar
• Qin C, Zhou P, Wang L, et al. Dl-3-N-butylphthalide attenuates ischemic reperfusion injury by improving the function of cerebral artery and circulation. J Cereb Blood Flow Metab. 2019;39(10):2011–2021. doi:10.1177/0271678X18776833
   PubMed Web of Science ®Google Scholar
• Yang CS, Guo A, Li Y, Shi K, Shi FD, Li M. Dl-3-n-butylphthalide reduces neurovascular inflammation and ischemic brain injury in mice. Aging Dis. 2019;10(5):964–976. doi:10.14336/AD.2019.0608
   PubMed Web of Science ®Google Scholar
• Yang LC, Li J, Xu SF, et al. L-3-n-butylphthalide promotes neurogenesis and neuroplasticity in cerebral ischemic rats. CNS Neurosci Ther. 2015;21(9):733–741. doi:10.1111/cns.12438
   PubMed Web of Science ®Google Scholar
• Liu S, Shi H, Liu W, Furuichi T, Timmins GS, Liu KJ. Interstitial pO2 in ischemic penumbra and core are differentially affected following transient focal cerebral ischemia in rats. J Cereb Blood Flow Metab. 2004;24(3):343–349. doi:10.1097/01.WCB.0000110047.43905.01
   PubMed Web of Science ®Google Scholar
• Atsumi S, Higashide W, Liao JC. Direct photosynthetic recycling of carbon dioxide to isobutyraldehyde. Nat Biotechnol. 2009;27(12):1177–1180. doi:10.1038/nbt.1586
   PubMed Web of Science ®Google Scholar
• Xu Y, Ma P, Shah P, Rokas A, Liu Y, Johnson CH. Non-optimal codon usage is a mechanism to achieve circadian clock conditionality. Nature. 2013;495(7439):116–120. doi:10.1038/nature11942
   PubMed Web of Science ®Google Scholar
• Cohen JE, Goldstone AB, Paulsen MJ, et al. An innovative biologic system for photon-powered myocardium in the ischemic heart. Sci Adv. 2017;3(6):e1603078. doi:10.1126/sciadv.1603078
   PubMed Web of Science ®Google Scholar
• Qiao Y, Yang F, Xie T, et al. Engineered algae: a novel oxygen-generating system for effective treatment of hypoxic cancer. Sci Adv. 2020;6(21):eaba5996. doi:10.1126/sciadv.aba5996
   PubMed Web of Science ®Google Scholar
• Weissleder R. A clearer vision for in vivo imaging. Nat Biotechnol. 2001;19(4):316–317. doi:10.1038/86684
   PubMed Web of Science ®Google Scholar
• Liu J, Pan L, Shang C, et al. A highly sensitive and selective nanosensor for near-infrared potassium imaging. Sci Adv. 2020;6(16):eaax9757. doi:10.1126/sciadv.aax9757
   PubMed Web of Science ®Google Scholar
• Byrdin M, Jordan P, Krauss N, Fromme P, Stehlik D, Schlodder E. Light harvesting in photosystem I: modeling based on the 2.5-A structure of photosystem I from Synechococcus elongatus. Biophys J. 2002;83(1):433–457. doi:10.1016/S0006-3495(02)75181-3
   PubMed Web of Science ®Google Scholar
• Dau H, Zaharieva I. Principles, efficiency, and blueprint character of solar-energy conversion in photosynthetic water oxidation. Acc Chem Res. 2009;42(12):1861–1870. doi:10.1021/ar900225y
   PubMed Web of Science ®Google Scholar
• Wang F, Deng R, Wang J, et al. Tuning upconversion through energy migration in core-shell nanoparticles. Nat Mater. 2011;10(12):968–973. doi:10.1038/nmat3149
   PubMed Web of Science ®Google Scholar
• Wang J, Wang F, Wang C, Liu Z, Liu X. Single-band upconversion emission in lanthanide-doped KMnF3 nanocrystals. Angew Chem Int Ed Engl. 2011;50(44):10369–10372. doi:10.1002/anie.201104192
   PubMed Web of Science ®Google Scholar
• Allen TM, Cullis PR. Liposomal drug delivery systems: from concept to clinical applications. Adv Drug Deliv Rev. 2013;65(1):36–48. doi:10.1016/j.addr.2012.09.037
   PubMed Web of Science ®Google Scholar
• Al-Ahmady ZS, Jasim D, Ahmad SS, et al. Selective liposomal transport through blood brain barrier disruption in ischemic stroke reveals two distinct therapeutic opportunities. ACS Nano. 2019;13(11):12470–12486. doi:10.1021/acsnano.9b01808
   PubMed Web of Science ®Google Scholar
• Terstappen GC, Meyer AH, Bell RD, Zhang W. Strategies for delivering therapeutics across the blood-brain barrier. Nat Rev Drug Discov. 2021;20(5):362–383. doi:10.1038/s41573-021-00139-y
   PubMed Web of Science ®Google Scholar
• Li C, Liu K, Liu S, Aerqin Q, Wu X. Role of ginkgolides in the inflammatory immune response of neurological diseases: a review of current literatures. Front Syst Neurosci. 2020;14:45. doi:10.3389/fnsys.2020.00045
   PubMed Web of Science ®Google Scholar
• Wei H, Sun T, Tian Y, Wang K. Ginkgolide B Modulates BDNF expression in acute ischemic stroke. J Korean Neurosurg Soc. 2017;60(4):391–396. doi:10.3340/jkns.2016.1010.018
   PubMed Web of Science ®Google Scholar
• Zheng PD, Mungur R, Zhou HJ, Hassan M, Jiang SN, Zheng JS. Ginkgolide B promotes the proliferation and differentiation of neural stem cells following cerebral ischemia/reperfusion injury, both in vivo and in vitro. Neural Regen Res. 2018;13(7):1204–1211. doi:10.4103/1673-5374.232476
   PubMed Web of Science ®Google Scholar
• Thid D, Benkoski JJ, Svedhem S, Kasemo B, Gold J. DHA-induced changes of supported lipid membrane morphology. Langmuir. 2007;23(11):5878–5881. doi:10.1021/la700523x
   PubMed Web of Science ®Google Scholar
• Yu WB, Cao L, Zhao YY, Xiao W, Xiao BG. Comparing the role of Ginkgolide B and Ginkgolide K on cultured astrocytes exposed to oxygen‑glucose deprivation. Mol Med Rep. 2018;18(5):4417–4427. doi:10.3892/mmr.2018.9450
   PubMed Web of Science ®Google Scholar
• Liao J, Gong L, Xu Q, et al. Revolutionizing neurocare: biomimetic nanodelivery via cell membranes. Adv Mater;2024. e2402445. doi:10.1002/adma.202402445
   PubMed Web of Science ®Google Scholar
• Jiang Y, Wang R, Wang C, et al. Brain microenvironment responsive and pro-angiogenic extracellular vesicle-hydrogel for promoting neurobehavioral recovery in type 2 diabetic mice after stroke. Adv Healthc Mater. 2022;11(22):e2201150. doi:10.1002/adhm.202201150
   PubMed Web of Science ®Google Scholar
• Bang OY, Kim EH. Mesenchymal stem cell-derived extracellular vesicle therapy for stroke: challenges and progress. Front Neurol. 2019;10:211. doi:10.3389/fneur.2019.00211
   PubMed Web of Science ®Google Scholar
• Reis C, Wilkinson M, Reis H, et al. A look into stem cell therapy: exploring the options for treatment of ischemic stroke. Stem Cells Int. 2017;2017:3267352. doi:10.1155/2017/3267352
   PubMed Web of Science ®Google Scholar
• Sakata H, Niizuma K, Yoshioka H, et al. Minocycline-preconditioned neural stem cells enhance neuroprotection after ischemic stroke in rats. J Neurosci. 2012;32(10):3462–3473. doi:10.1523/JNEUROSCI.5686-11.2012
   PubMed Web of Science ®Google Scholar
• Dao M, Tate CC, McGrogan M, Case CC. Comparing the angiogenic potency of naive marrow stromal cells and Notch-transfected marrow stromal cells. J Transl Med. 2013;11:81. doi:10.1186/1479-5876-11-81
   PubMed Web of Science ®Google Scholar
• Noiseux N, Gnecchi M, Lopez-Ilasaca M, et al. Mesenchymal stem cells overexpressing Akt dramatically repair infarcted myocardium and improve cardiac function despite infrequent cellular fusion or differentiation. Mol Ther. 2006;14(6):840–850. doi:10.1016/j.ymthe.2006.05.016
   PubMed Web of Science ®Google Scholar
• Lu D, Chen B, Liang Z, et al. Comparison of bone marrow mesenchymal stem cells with bone marrow-derived mononuclear cells for treatment of diabetic critical limb ischemia and foot ulcer: a double-blind, randomized, controlled trial. Diabet Res Clin Pract. 2011;92(1):26–36. doi:10.1016/j.diabres.2010.12.010
   PubMed Web of Science ®Google Scholar
• Abdal Dayem A, Lee SB, Kim K, et al. Production of mesenchymal stem cells through stem cell reprogramming. Int J Mol Sci. 2019;20(8):1922. doi:10.3390/ijms20081922
   PubMed Web of Science ®Google Scholar
• Venkat P, Chen J, Chopp M. Exosome-mediated amplification of endogenous brain repair mechanisms and brain and systemic organ interaction in modulating neurological outcome after stroke. J Cereb Blood Flow Metab. 2018;38(12):2165–2178. doi:10.1177/0271678X18782789
   PubMed Web of Science ®Google Scholar
• Zhang ZG, Buller B, Chopp M. Exosomes - beyond stem cells for restorative therapy in stroke and neurological injury. Nat Rev Neurol. 2019;15(4):193–203. doi:10.1038/s41582-018-0126-4
   PubMed Web of Science ®Google Scholar
• Kishore R, Khan M. More than tiny sacks: stem cell exosomes as cell-free modality for cardiac repair. Circ Res. 2016;118(2):330–343. doi:10.1161/CIRCRESAHA.115.307654
   PubMed Web of Science ®Google Scholar
• Zhang ZG, Chopp M. Neurorestorative therapies for stroke: underlying mechanisms and translation to the clinic. Lancet Neurol. 2009;8(5):491–500. doi:10.1016/S1474-4422(09)70061-4
   PubMed Web of Science ®Google Scholar
• Jiang X, Suenaga J, Pu H, et al. Post-stroke administration of omega-3 polyunsaturated fatty acids promotes neurovascular restoration after ischemic stroke in mice: efficacy declines with aging. Neurobiol Dis. 2019;126:62–75. doi:10.1016/j.nbd.2018.09.012
   PubMed Web of Science ®Google Scholar
• Fei X, Zhang X, Wang Q, et al. Xijiao dihuang decoction alleviates ischemic brain injury in MCAO rats by regulating inflammation, neurogenesis, and angiogenesis. Evid Based Complement Alternat Med. 2018;2018:5945128. doi:10.1155/2018/5945128
   PubMed Web of Science ®Google Scholar
• Doeppner TR, Herz J, Gorgens A, et al. Extracellular vesicles improve post-stroke neuroregeneration and prevent postischemic immunosuppression. Stem Cells Transl Med. 2015;4(10):1131–1143. doi:10.5966/sctm.2015-0078
   PubMed Web of Science ®Google Scholar
• Xin H, Katakowski M, Wang F, et al. MicroRNA cluster miR-17-92 cluster in exosomes enhance neuroplasticity and functional recovery after stroke in rats. Stroke. 2017;48(3):747–753. doi:10.1161/STROKEAHA.116.015204
   PubMed Web of Science ®Google Scholar
• Xin H, Li Y, Cui Y, Yang JJ, Zhang ZG, Chopp M. Systemic administration of exosomes released from mesenchymal stromal cells promote functional recovery and neurovascular plasticity after stroke in rats. J Cereb Blood Flow Metab. 2013;33(11):1711–1715. doi:10.1038/jcbfm.2013.152
   PubMed Web of Science ®Google Scholar
• Wang C, Borger V, Sardari M, et al. Mesenchymal stromal cell-derived small extracellular vesicles induce ischemic neuroprotection by modulating leukocytes and specifically neutrophils. Stroke. 2020;51(6):1825–1834. doi:10.1161/STROKEAHA.119.028012
   PubMed Web of Science ®Google Scholar
• De Palma M, Biziato D, Petrova TV. Microenvironmental regulation of tumour angiogenesis. Nat Rev Cancer. 2017;17(8):457–474. doi:10.1038/nrc.2017.51
   PubMed Web of Science ®Google Scholar
• Lee JK, Park SR, Jung BK, et al. Exosomes derived from mesenchymal stem cells suppress angiogenesis by down-regulating VEGF expression in breast cancer cells. PLoS One. 2013;8(12):e84256. doi:10.1371/journal.pone.0084256
   PubMed Web of Science ®Google Scholar
• Gonzalez-King H, Garcia NA, Ontoria-Oviedo I, Ciria M, Montero JA, Sepulveda P. Hypoxia Inducible Factor-1alpha Potentiates Jagged 1-mediated angiogenesis by mesenchymal stem cell-derived exosomes. Stem Cells. 2017;35(7):1747–1759. doi:10.1002/stem.2618
   PubMed Web of Science ®Google Scholar
• Kornhuber J, Muller CP, Becker KA, Reichel M, Gulbins E. The ceramide system as a novel antidepressant target. Trends Pharmacol Sci. 2014;35(6):293–304. doi:10.1016/j.tips.2014.04.003
   PubMed Web of Science ®Google Scholar
• Deng X, Yin X, Allan R, et al. Ceramide biogenesis is required for radiation-induced apoptosis in the germ line of C. elegans. Science. 2008;322(5898):110–115. doi:10.1126/science.1158111
   PubMed Web of Science ®Google Scholar
• Gulbins E, Palmada M, Reichel M, et al. Acid sphingomyelinase-ceramide system mediates effects of antidepressant drugs. Nat Med. 2013;19(7):934–938. doi:10.1038/nm.3214
   PubMed Web of Science ®Google Scholar
• Brunkhorst R, Friedlaender F, Ferreiros N, et al. Alterations of the ceramide metabolism in the peri-infarct cortex are independent of the sphingomyelinase pathway and not influenced by the acid sphingomyelinase inhibitor fluoxetine. Neural Plast. 2015;2015:503079.
   PubMed Web of Science ®Google Scholar
• Herr I, Martin-Villalba A, Kurz E, et al. FK506 prevents stroke-induced generation of ceramide and apoptosis signaling. Brain Res. 1999;826(2):210–219. doi:10.1016/S0006-8993(99)01288-3
   PubMed Web of Science ®Google Scholar
• Ohtani R, Tomimoto H, Kondo T, et al. Upregulation of ceramide and its regulating mechanism in a rat model of chronic cerebral ischemia. Brain Res. 2004;1023(1):31–40. doi:10.1016/j.brainres.2004.07.024
   PubMed Web of Science ®Google Scholar
• Yu ZF, Nikolova-Karakashian M, Zhou D, Cheng G, Schuchman EH, Mattson MP. Pivotal role for acidic sphingomyelinase in cerebral ischemia-induced ceramide and cytokine production, and neuronal apoptosis. J Mol Neurosci. 2000;15(2):85–97. doi:10.1385/JMN:15:2:85
   PubMed Web of Science ®Google Scholar
• Kanazawa M, Miura M, Toriyabe M, et al. Microglia preconditioned by oxygen-glucose deprivation promote functional recovery in ischemic rats. Sci Rep. 2017;7:42582. doi:10.1038/srep42582
   PubMed Web of Science ®Google Scholar
• Wattananit S, Tornero D, Graubardt N, et al. Monocyte-derived macrophages contribute to spontaneous long-term functional recovery after stroke in mice. J Neurosci. 2016;36(15):4182–4195. doi:10.1523/JNEUROSCI.4317-15.2016
   PubMed Web of Science ®Google Scholar
• Yu Y, Li J, Zhou H, et al. Functional importance of the TGF-beta1/Smad3 signaling pathway in oxygen-glucose-deprived (OGD) microglia and rats with cerebral ischemia. Int J Biol Macromol. 2018;116:537–544. doi:10.1016/j.ijbiomac.2018.04.113
   PubMed Web of Science ®Google Scholar
• Butovsky O, Jedrychowski MP, Moore CS, et al. Identification of a unique TGF-beta-dependent molecular and functional signature in microglia. Nat Neurosci. 2014;17(1):131–143. doi:10.1038/nn.3599
   PubMed Web of Science ®Google Scholar
• Krueger TEG, Thorek DLJ, Denmeade SR, Isaacs JT, Brennen WN. Concise Review: mesenchymal Stem Cell-Based Drug Delivery: the Good, the Bad, the Ugly, and the Promise. Stem Cells Transl Med. 2018;7(9):651–663. doi:10.1002/sctm.18-0024
   PubMed Web of Science ®Google Scholar
• Prockop DJ, Brenner M, Fibbe WE, et al. Defining the risks of mesenchymal stromal cell therapy. Cytotherapy. 2010;12(5):576–578. doi:10.3109/14653249.2010.507330
   PubMed Web of Science ®Google Scholar
• Tieu A, Slobodian M, Fergusson DA, et al. Methods and efficacy of extracellular vesicles derived from mesenchymal stromal cells in animal models of disease: a preclinical systematic review protocol. Syst Rev. 2019;8(1):322. doi:10.1186/s13643-019-1242-y
   PubMed Web of Science ®Google Scholar
• Go V, Bowley BGE, Pessina MA, et al. Extracellular vesicles from mesenchymal stem cells reduce microglial-mediated neuroinflammation after cortical injury in aged Rhesus monkeys. Geroscience. 2020;42(1):1–17. doi:10.1007/s11357-019-00115-w
   PubMed Web of Science ®Google Scholar
• Webb RL, Kaiser EE, Scoville SL, et al. Human neural stem cell extracellular vesicles improve tissue and functional recovery in the murine thromboembolic stroke model. Transl Stroke Res. 2018;9(5):530–539. doi:10.1007/s12975-017-0599-2
   PubMed Web of Science ®Google Scholar
• Anderson JD, Johansson HJ, Graham CS, et al. Comprehensive proteomic analysis of mesenchymal stem cell exosomes reveals modulation of angiogenesis via nuclear factor-kappaB signaling. Stem Cells. 2016;34(3):601–613. doi:10.1002/stem.2298
   PubMed Web of Science ®Google Scholar
• Zheng X, Zhang L, Kuang Y, et al. Extracellular vesicles derived from neural progenitor cells--a preclinical evaluation for stroke treatment in mice. Transl Stroke Res. 2021;12(1):185–203. doi:10.1007/s12975-020-00814-z
   PubMed Web of Science ®Google Scholar
• Yu Z, Cai Y, Deng M, et al. Fat extract promotes angiogenesis in a murine model of limb ischemia: a novel cell-free therapeutic strategy. Stem Cell Res Ther. 2018;9(1):294. doi:10.1186/s13287-018-1014-y
   PubMedGoogle Scholar
• Zheng H, Yu Z, Deng M, et al. Fat extract improves fat graft survival via proangiogenic, anti-apoptotic and pro-proliferative activities. Stem Cell Res Ther. 2019;10(1):174. doi:10.1186/s13287-019-1290-1
   PubMedGoogle Scholar
• Dong X, Gao J, Zhang CY, Hayworth C, Frank M, Wang Z. Neutrophil membrane-derived nanovesicles alleviate inflammation to protect mouse brain injury from ischemic stroke. ACS Nano. 2019;13(2):1272–1283. doi:10.1021/acsnano.8b06572
   PubMed Web of Science ®Google Scholar
• Dehaini D, Wei X, Fang RH, et al. Erythrocyte-platelet hybrid membrane coating for enhanced nanoparticle functionalization. Adv Mater. 2017;29(16). doi:10.1002/adma.201606209
   Web of Science ®Google Scholar
• Li M, Li J, Chen J, et al. Platelet membrane biomimetic magnetic nanocarriers for targeted delivery and in situ generation of nitric oxide in early ischemic stroke. ACS Nano. 2020;14(2):2024–2035. doi:10.1021/acsnano.9b08587
   PubMed Web of Science ®Google Scholar
• Xu L, Chen Y, Jin Q, et al. Biomimetic PLGA microbubbles coated with platelet membranes for early detection of myocardial ischaemia-reperfusion injury. Mol Pharm. 2021;18(8):2974–2985. doi:10.1021/acs.molpharmaceut.1c00145
   PubMedGoogle Scholar
• Parvez S, Kaushik M, Ali M, et al. Dodging blood brain barrier with ”nano” warriors: novel strategy against ischemic stroke. Theranostics. 2022;12(2):689–719. doi:10.7150/thno.64806
   PubMed Web of Science ®Google Scholar
• Sri Kanaka Durga Vijayalakshmi G, Puvvada N. Recent advances in chemically engineered nanostructures impact on ischemic stroke treatment. ACS Omega. 2023;8(48):45188–45207. doi:10.1021/acsomega.3c06228
   PubMed Web of Science ®Google Scholar
• Li C, Sun T, Jiang C. Recent advances in nanomedicines for the treatment of ischemic stroke. Acta Pharm Sin B. 2021;11(7):1767–1788. doi:10.1016/j.apsb.2020.11.019
   PubMed Web of Science ®Google Scholar
• Wang Z, Zhao Y, Jiang Y, et al. Enhanced anti-ischemic stroke of ZL006 by T7-conjugated PEGylated liposomes drug delivery system. Sci Rep. 2015;5:12651. doi:10.1038/srep12651
   PubMed Web of Science ®Google Scholar
• Lv W, Xu J, Wang X, et al. Bioengineered boronic ester modified dextran polymer nanoparticles as reactive oxygen species responsive nanocarrier for ischemic stroke treatment. ACS Nano. 2018;12(6):5417–5426. doi:10.1021/acsnano.8b00477
   PubMed Web of Science ®Google Scholar
• Bao Q, Hu P, Xu Y, et al. Simultaneous blood-brain barrier crossing and protection for stroke treatment based on edaravone-loaded ceria nanoparticles. ACS Nano. 2018;12(7):6794–6805. doi:10.1021/acsnano.8b01994
   PubMed Web of Science ®Google Scholar
• Wong HL, Wu XY, Bendayan R. Nanotechnological advances for the delivery of CNS therapeutics. Adv Drug Deliv Rev. 2012;64(7):686–700. doi:10.1016/j.addr.2011.10.007
   PubMed Web of Science ®Google Scholar
• Saraiva C, Praca C, Ferreira R, Santos L, Ferreira L, Bernardino L. Bernardino, Nanoparticle-mediated brain drug delivery: overcoming blood-brain barrier to treat neurodegenerative diseases. J Control Release. 2016;235:34–47. doi:10.1016/j.jconrel.2016.05.044
   PubMed Web of Science ®Google Scholar
• Tian T, Zhang HX, He CP, et al. Surface functionalized exosomes as targeted drug delivery vehicles for cerebral ischemia therapy. Biomaterials. 2018;150:137–149. doi:10.1016/j.biomaterials.2017.10.012
   PubMed Web of Science ®Google Scholar